Centralised versus outreach models of cystic fibrosis care should be tailored to the needs of the individual patient
Corresponding Author
James Geake
Department of Respiratory and Sleep Medicine, Lyell McEwin Hospital, Adelaide, South Australia, Australia
Department of Respiratory and Sleep Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Correspondence
James Geake, Lyell McEwin Hospital, Haydown Road Elizabeth Vale, SA 5112, Australia.
Email: [email protected]
Search for more papers by this authorEmma Ballard
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Search for more papers by this authorPeter O'Rourke
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Search for more papers by this authorClaire E. Wainwright
Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
Search for more papers by this authorDavid W. Reid
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorScott C. Bell
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorCorresponding Author
James Geake
Department of Respiratory and Sleep Medicine, Lyell McEwin Hospital, Adelaide, South Australia, Australia
Department of Respiratory and Sleep Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Correspondence
James Geake, Lyell McEwin Hospital, Haydown Road Elizabeth Vale, SA 5112, Australia.
Email: [email protected]
Search for more papers by this authorEmma Ballard
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Search for more papers by this authorPeter O'Rourke
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Search for more papers by this authorClaire E. Wainwright
Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
Search for more papers by this authorDavid W. Reid
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorScott C. Bell
Department of Lung Inflammation and Infection, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorAbstract
Cystic fibrosis (CF) is a common life-limiting genetic condition. As the disease progresses access to specialist tertiary multi-disciplinary care services may become necessary. For patients living in regional/remote Australia, accessing such services may be a challenge. Here, we describe long-term outcomes for CF patients according to their access to specialist CF centre care in childhood.
References
- 1Collins CE, MacDonald-Wicks L, Rowe S, O'Loughlin EV, Henry RL. Normal growth in cystic fibrosis associated with a specialised Centre. Arch Dis Child 1999; 81: 241–6.
- 2Doull I, Evans H, South and Mid Wales Paediatric Cystic Fibrosis Net work. Full, shared and hybrid paediatric care for cystic fibrosis in South and Mid Wales. Arch Dis Child 2012; 97: 17–20.
- 3Hill DJ, Martin AJ, Davidson GP, Smith GS. Survival of cystic fibrosis patients in South Australia. Evidence that cystic fibrosis centre care leads to better survival. Med J Aust 1985; 143: 230–2.
- 4Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998; 316: 1771–5.
- 5Bowler I, Pierrepoint M, Evans R. Response to ‘full, shared and hybrid paediatric care for cystic fibrosis (CF) in South and Mid Wales’. Arch Dis Child 2012; 97: 88, author reply 9–90.
- 6Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001; 18: 306–15.
- 7Thomas CL, O'Rourke PK, Wainwright CE. Clinical outcomes of Queensland children with cystic fibrosis: a comparison between tertiary centre and outreach services. Med J Aust 2008; 188: 135–9.
- 8Harun SN, Wainwright C, Klein K, Hennig S. A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis. Paediatr Respir Rev 2016; 20: 55–66.
- 9Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J 2014; 43: 125–33.
- 10Nkam L, Lambert J, Latouche A, Bellis G, Burgel PR, Hocine MN. A 3-year prognostic score for adults with cystic fibrosis. J Cyst Fibros 2017; 16: 702–8.
